Yes. Medication-assisted treatment pairs FDA-approved medicines with counseling. For opioid addiction, methadone and buprenorphine calm cravings and withdrawal and are linked to fewer overdose deaths. For alcohol, naltrexone, acamprosate and disulfiram are approved and not addictive. The catch for families is that not every program allows these medicines, so ask before admission.
What is medication-assisted treatment (MAT)?
You may also see it called “medications for addiction treatment” or, for opioids, MOUD (medications for opioid use disorder). SAMHSA describes medication combined with counseling and behavioral therapy as a “whole-patient” approach, and says research shows the combination can successfully treat substance use disorders.1 It can be part of care almost anywhere, from a regular office visit to residential treatment. For how those settings fit together, see the main types of addiction treatment.
Is medication just trading one drug for another?
No. SAMHSA says these medications are evidence-based treatment and “do not just substitute one drug for another.”1 The worry usually comes from mixing up two different things.
Physical dependence means the body has adjusted to a medicine and would go through withdrawal if it stopped suddenly. Someone on methadone or buprenorphine can have withdrawal if they stop abruptly, but SAMHSA notes that this alone isn’t a disorder.2 Addiction is compulsive use despite harm: chasing a high, losing control, lying, missing work. A person stable on a steady, prescribed dose is dependent on a medicine that relieves the cravings and withdrawal driving that cycle.1
What medications treat opioid use disorder?
Three are FDA-approved, and they work in different ways.52
| Medication | How it works | Where you get it | Good to know |
|---|---|---|---|
| Methadone | A long-acting opioid that reduces craving and withdrawal and blunts the effects of other opioids6 | Only at a certified opioid treatment program (OTP) when used for addiction6 | Taken daily; take-home doses are possible after a period of stability6 |
| Buprenorphine (Suboxone, generics, long-acting injections) | A partial opioid that relieves withdrawal and cravings, with weaker effects like slowed breathing than full opioids7 | A regular doctor’s office, or some OTPs. Film, tablet or long-acting injection75 | Starting while other opioids are still in the body can bring on sudden withdrawal, so timing matters7 |
| Extended-release naltrexone (Vivitrol) | Blocks opioids from working. It is not an opioid and is not addictive8 | A monthly injection from a clinician8 | They must be off opioids first: at least 7 days after short-acting opioids, 10 to 14 days after long-acting ones8 |
As for buprenorphine versus methadone, neither is best for everyone. SAMHSA says the choice should fit the patient, shaped by their medical and substance use history, their preference and what’s available nearby.16 Their schedule, other health conditions and distance from a clinic matter too. What you can do is make sure the program your loved one picks can actually offer that choice.
Does medication lower the risk of overdose?
Yes. Medications for opioid use disorder help people stay in treatment, use fewer illicit opioids and survive, and methadone and buprenorphine in particular are associated with significant reductions in the risk of overdose death.12
That protection counts most after a break from opioids. Tolerance drops during detox, jail or a hospital stay, and SAMHSA lists returning to drug use after leaving one of those settings without medication as an overdose risk factor.2 CDC provisional data put U.S. overdose deaths at 69,973 in 2025, about 44,564 of them involving opioids. That is the third straight yearly decline, though the figures may change as data are finalized.9
Medication doesn’t replace naloxone, which SAMHSA advises families of people who use opioids to keep at home.2 Here’s how to use naloxone.
What medications help with alcohol use disorder?
Naltrexone, acamprosate and disulfiram are approved, and they are vastly underused, so ask about them by name.11
- Naltrexone (a daily pill or monthly injection) can reduce cravings and how much someone drinks.118 It isn’t for people who currently use or depend on opioids, including opioid pain medicine.8
- Acamprosate helps people who have already stopped drinking stay stopped.11
- Disulfiram causes an unpleasant reaction if the person drinks. It suits people aiming not to drink at all, and may work better if someone watches them take it each day.12
A primary care provider can prescribe any of these, alone or with counseling.10 The American Psychiatric Association also suggests gabapentin or topiramate as second-line options for some patients.11 If your loved one drinks heavily every day, stopping suddenly can be dangerous, so read about alcohol withdrawal before they quit.10
What about meth, cocaine and other stimulants?
No medication is FDA-approved for stimulant use disorder yet.34 Behavioral therapies can work, including cognitive behavioral therapy and contingency management, which gives vouchers or other rewards for not using.4 A clinician can still treat what often comes along with stimulant use, such as depression or anxiety; see treating addiction and mental health together.
How long does someone stay on medication?
There’s no set end date. SAMHSA says medications for opioid use disorder are safe to use for months, years or a lifetime.27 Staying on long term is not a failure.
If your loved one wants to come off, that’s a plan to make with the prescriber, who can lower the dose gradually to prevent withdrawal.6 Quitting on their own is the risky version: tolerance falls, and with naltrexone the block wears off, so an amount they used to take, or even less, can be deadly.28
What if a treatment program won’t allow medication?
Look for one that will. SAMHSA’s checklist for finding quality treatment tells families to ask about treatment with medication, because not every program offers or allows it.3
Kim’s son Eli, 26, had been stable on buprenorphine for four months when his depression got worse and his counselor suggested residential care. The first program Kim called said Eli would have to taper off before admission. The second said it would continue his prescription and coordinate with his doctor. Eli went there and came home with a follow-up appointment already booked.
Medication questions to ask
- Ask any program before admission
- Ask the prescriber
Where can my loved one get these medications, and who pays?
To find a prescriber or program, search FindTreatment.gov, SAMHSA’s locator of state-licensed providers.14 The free, confidential SAMHSA National Helpline at 1-800-662-4357 also gives referrals around the clock, in English and Spanish.15
Federal law requires state Medicaid programs to cover medications for opioid use disorder and related counseling,16 and a 2024 law made that permanent.17 Medicare Part B covers methadone, buprenorphine and naltrexone given in a doctor’s office or an opioid treatment program, plus counseling and drug testing at a program.18 With a private plan, ask member services how each medication is covered and whether it needs prior authorization. If the plan limits addiction medication more strictly than other medical care, read about appeals and parity rights.
How can families help someone stay on medication?
Make staying on it easier. Drive them to clinic visits, help set up a pharmacy routine, keep the medication locked away from children and pets, and notice that they keep showing up rather than counting days.17 If they use again, the next step is a call to the prescriber, who may adjust the dose or add support, not stopping the medication.17 Our guide to responding when a loved one uses again covers the rest.
What you say about the medication matters too.
What to say instead
“You’re still on drugs, just a different kind.”
“I’m glad you’re getting treatment. How is the medication working for you?”
“When are you getting off that stuff?”
“That’s a decision for you and your doctor. I’m here to help however I can.”
Frequently asked questions
Can someone on buprenorphine or methadone live in sober living?
Often, yes, but policies vary. Recovery homes set their own rules, so ask before they move in. Our guide to choosing a recovery home covers what else to ask.
Is medication safe during pregnancy?
The American College of Obstetricians and Gynecologists says the best treatment for opioid use disorder in pregnancy includes methadone or buprenorphine, along with behavioral therapy and counseling. It also warns against stopping opioids without medical supervision, because quitting suddenly often leads to a return to use.13 See treatment during pregnancy.
Is it safe to take buprenorphine or methadone with alcohol or benzodiazepines?
The combination raises overdose risk, including breathing that slows or stops.219 Even so, the FDA has advised that buprenorphine and methadone shouldn’t be withheld from people who also take benzodiazepines, because untreated opioid addiction can do more harm, and careful medication management can reduce the risk.20 Make sure every prescriber knows everything your loved one takes.
Sources
- SAMHSA — Treatment Options for Substance Use Disorder (updated August 2025). samhsa.gov/substance-use/treatment/options — accessed Oct 2026
- SAMHSA — Overdose Prevention and Response Toolkit, PEP23-03-00-001 (updated May 2026). samhsa.gov/sites/default/files/overdose-prevention-response-kit-pep23-… — accessed Oct 2026
- SAMHSA — Quality Treatment for Mental Health, Drugs and Alcohol (last updated 2023). samhsa.gov/find-support/learn-about-treatment/finding-quality-treatmen… — accessed Oct 2026
- SAMHSA — Stimulants (updated November 2024). samhsa.gov/substance-use/learn/stimulants — accessed Oct 2026
- FDA — Information about Medications for Opioid Use Disorder (MOUD). fda.gov/drugs/food-and-drug-administration-overdose-prevention-framewo… — accessed Oct 2026
- SAMHSA — Methadone (updated December 2025). samhsa.gov/substance-use/treatment/options/methadone — accessed Oct 2026
- SAMHSA — Buprenorphine (updated April 2026). samhsa.gov/substance-use/treatment/options/buprenorphine — accessed Oct 2026
- SAMHSA — Naltrexone (updated December 2025). samhsa.gov/substance-use/treatment/options/naltrexone — accessed Oct 2026
- CDC National Center for Health Statistics — U.S. Overdose Deaths Decrease for Third Consecutive Year in 2025 (May 13, 2026). cdc.gov/nchs/pressroom/releases/20260513.html — accessed Oct 2026
- NIAAA — Treatment for Alcohol Problems: Finding and Getting Help (updated February 2025). niaaa.nih.gov/publications/brochures-and-fact-sheets/treatment-alcohol… — accessed Oct 2026
- NIAAA — Recommend Evidence-Based Treatment: Know the Options (Core Resource on Alcohol). niaaa.nih.gov/health-professionals-communities/core-resource-on-alcoho… — accessed Oct 2026
- SAMHSA — Disulfiram (updated August 2025). samhsa.gov/substance-use/treatment/options/disulfiram — accessed Oct 2026
- American College of Obstetricians and Gynecologists — Opioid Use Disorder and Pregnancy (patient FAQ). acog.org/womens-health/faqs/opioid-use-disorder-and-pregnancy — accessed Oct 2026
- SAMHSA — Find Substance Use Disorder Treatment. samhsa.gov/substance-use/treatment/find-treatment — accessed Oct 2026
- SAMHSA — National Helpline. samhsa.gov/find-help/helplines/national-helpline — accessed Oct 2026
- CMS — State Health Official Letter #20-005: Mandatory Medicaid State Plan Coverage of Medication-Assisted Treatment (Dec 30, 2020). medicaid.gov/federal-policy-guidance/downloads/sho20005.pdf — accessed Oct 2026
- CMS — State Medicaid Director Letter #24-004: Extension of Medicaid Coverage of Substance Use Disorder Treatment in the Consolidated Appropriations Act, 2024 (November 19, 2024). medicaid.gov/federal-policy-guidance/downloads/smd24004.pdf — accessed Oct 2026
- Medicare.gov — Opioid Use Disorder Treatment Services. medicare.gov/coverage/opioid-use-disorder-treatment-services — accessed Oct 2026
- FDA — FDA requiring Boxed Warning updated to improve safe use of benzodiazepine drug class, Drug Safety Communication (September 23, 2020). fda.gov/drugs/drug-safety-and-availability/fda-requiring-boxed-warning… — accessed Oct 2026
- FDA — Timeline of Selected FDA Activities and Significant Events Addressing Substance Use and Overdose Prevention (entry for Sept 20, 2017). fda.gov/drugs/food-and-drug-administration-overdose-prevention-framewo… — accessed Oct 2026